Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
Keratitis
About this trial
This is an interventional treatment trial for Keratitis focused on measuring Microbial keratitis
Eligibility Criteria
Inclusion Criteria: Patients with active microbial keratitis ( bacterial , viral or fungal ) with positive culture and sensitivity result Any age group. accepting well informed consent for using the ozone eye drops Exclusion Criteria: patients refuse to participate Patients with other forms of keratitis rather than infective keratitis . patients who will not complete treatment .
Sites / Locations
Arms of the Study
Arm 1
Experimental
Infective keratitis
Preparation of nanostructure lipid carriers (NLCs): The emulsification-solvent evaporation technique was used to prepare the NLCs. The method was followed by ultrasonication as reported [1]. In brief, the lipid phase was composed of stearic acid (solid lipid, 300 mg and oleic acid (liquid lipid, 300 mg) dissolved in ethanol (2 mL, 1:1, v/v) at 70oC. In total, 20 mL of the distilled water containing 2% of the Tween® 80 were heated at 70 oC to prepare the aqueous phase. Then, both phases, aqueous and lipid phases, were mixed at the same temperature using 2000 rpm stirring for 15 min. The resulting pre-emulsion obtained from the mixture of the aqueous and lipid phases was sonicated by a probe-type sonicator (Cole-Parmer, Vernon Hills, IL, USA) for 10 min at pulse-ON for 3 s and pulse-OFF for 5 s (40 W). The obtained dispersion was allowed to cool to RT under continuous stirring for 60 min at 1000 rpm for 1 h to obtain the NLCs dispersions.